Study may improve clinical trials of therapeutics aimed at curing human immunodeficiency virus, UW Medicine researcher says.
More study is needed to know whether this change improves antiviral defenses or causes harmful inflammation, UW Medicine researchers say.
“We wanted to answer the question ‘How does HIV bounce back when treatment is stopped?'" said Dr. Florian Hladik.
Wound-repair capabilities preserve tissue integrity during early infection and might prevent inflammation that underlies immune exhaustion.
The numbers of new diagnoses are at their lowest level in decades.
Researchers have found that breastfeeding mothers taking the antiretroviral drugs tenofovir and emtricitabine have a low risk of side effects.
[See related KOMO-4 News' Dec. 1 story.]
Visitors to the AIDS Outreach Clinic in Bozeman, Montana usually come alone, or sometimes with a friend.
